ACT SMART Q ACTILYSE 50mg Previous Next ACT SMART Q: Network Approach in Stroke Care 19/05/2025 | Author: Boehringer Ingelheim Document ID: PC-SG-102801 ACTILYSE 50mg ACT SMART Q: Network Approach in Stroke Care How to Use the Modified Rankin Scale | Dr. Tan Wee Yong The Efficacy and Safety Profile of Actilyse Bleeding Rates of Alteplase | Dr. Tan Wee Yong Post-rtPA Symptoms to Monitor | Dr. Tan Wee Yong rtPA Use Without Visible Occlusion | Dr. Tan Wee Yong Managing Post-rtPA ICH in Stroke | Dr. Tan Wee Yong AIS Early Management Guidelines | Dr. Macrohon Valdez Early Treatment in AIS Matters | Dr. Macrohon Valdez Alteplase Dosing in Stroke Care | Dr. Macrohon Valdez Role of Alteplase | Alteplase Use in Young & Old Stroke Understanding NIHSS Score Limits | Dr. Macrohon Valdez Essential Setup Without Specialists for Stroke Units Bridging Therapy and Sweet Spot to Use Alteplase Stroke Fast Track (SFT) | Emergency Stroke Care System ACT SMART Q: Improving Stroke Care in Thailand RELATED CONTENT Read more 1:51 How to Use the Modified Rankin Scale | Dr. Tan Wee Yong Watch now Opens in new tab Read more 1:20 The Efficacy and Safety Profile of Actilyse Watch now Opens in new tab Read more 1:22 Bleeding Rates of Alteplase | Dr. Tan Wee Yong Watch now Opens in new tab Read more 1:01 Post-rtPA Symptoms to Monitor | Dr. Tan Wee Yong Watch now Opens in new tab Read more 0:59 rtPA Use Without Visible Occlusion | Dr. Tan Wee Yong Watch now Opens in new tab Read more 1:35 Managing Post-rtPA ICH in Stroke | Dr. Tan Wee Yong Watch now Opens in new tab Pagination Load more